Veterinary Pharmacovigilance Market to Hit USD 3,257.51 Million by 2034, Registering a CAGR of 13.6%

BySheetal Gajbhiye

Global Veterinary Pharmacovigilance Market size and share is currently valued at USD 912.14 million in 2024 and is anticipated to generate an estimated revenue of USD 3,257.51 million by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 13.6% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2025 – 2034

Market Definition

The veterinary pharmacovigilance market encompasses the monitoring, detection, assessment, and prevention of adverse effects or any drug-related problems in animals. It plays a crucial role in ensuring the safety and efficacy of veterinary medicines, covering both companion and food-producing animals. This market involves collaboration between pharmaceutical companies, veterinary healthcare providers, regulatory agencies, and surveillance networks. Growth is driven by increasing awareness of animal welfare, stringent regulations around drug usage in livestock, and rising global pet ownership. Technological tools such as real-time databases, AI-driven analytics, and mobile applications for reporting side effects are enhancing data collection and response efficiency. The market supports transparency and accountability in the animal health sector, ensuring that medications are continually evaluated post-market. It also contributes to food safety by minimizing drug residues in animal-derived products. As veterinary therapeutics evolve, the pharmacovigilance market remains critical to the sustainable and ethical use of veterinary pharmaceuticals.

Key Report Highlights  

  • The report highlights the key region that accounts for the highest revenue share in the global Veterinary Pharmacovigilance market.
  • It identifies the leading country within this region that makes a significant contribution to the market’s overall performance.
  • The report outlines the dominant segment that holds a major share of the market.
  • It also emphasizes the fastest-growing segment projected to gain strong traction during the forecast period.
  • Qualitative and quantitative market analysis have been used to provide an in-depth understanding of the market.

Market Overview: Key Figures at a Glance

  • Market Value in 2024: USD 912.14 million
  • Projected Market Size in 2034: USD 3,257.51 million
  • Anticipated CAGR (2025-2034): 13.6%

Get access to the full report or request a complimentary sample for in-depth analysis:

https://www.polarismarketresearch.com/industry-analysis/veterinary-pharmacovigilance-market/request-for-sample 

Market Growth Drivers

The increasing global awareness of animal health and welfare significantly drives the veterinary pharmacovigilance market. With growing concerns over zoonotic diseases and the responsible use of veterinary pharmaceuticals, governments and organizations are prioritizing surveillance systems to monitor adverse drug reactions in animals. Regulatory authorities, such as the European Medicines Agency (EMA) and the U.S. FDA, are implementing stricter guidelines to ensure drug safety and efficacy, propelling demand for comprehensive pharmacovigilance systems. Rising pet ownership, coupled with increased livestock production, particularly in emerging markets, is expanding the veterinary pharmaceutical landscape, necessitating enhanced monitoring. Technological advancements in data collection, artificial intelligence, and electronic health records enable more efficient detection and reporting of adverse events. Moreover, pharmaceutical companies are investing in robust safety protocols as part of their post-marketing surveillance strategies. As consumer demand for safe animal-derived products intensifies, the veterinary pharmacovigilance market continues to gain relevance and regulatory support across the globe.

Market Key Players

The competitive landscape features a mix of long-standing companies and emerging contenders. Leading players are actively pursuing R&D initiatives and strategic moves to strengthen their market position. Notable participants include

  • Accenture
  • ArisGlobal
  • Azierta Contract Science Support Consulting
  • Biologit
  • Ennov
  • Indivirtus
  • Knoell
  • Oy Medfiles Ltd.
  • Pharsafer Associates Limited
  • Sarjen Systems Pvt. Ltd.

Similar Posts